Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter Clinical Trial Evaluating the Use of [18F]-APN-1607 Injection in Positron Emission Tomography in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

NCT07422857 is registered in ClinicalTrials.gov with JYAMS PET Research & Development Limited as lead sponsor.

NCT NCT07422857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter Clinical Trial Evaluating the Use of [18F]-APN-1607 Injection in Positron Emission Tomography in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
Lead sponsor
JYAMS PET Research & Development Limited
Phase
Phase 3
Overall status
Recruiting
Start date
January 22, 2026
Completion date
February 1, 2027
Enrollment
316 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

subjects with mild cognitive impairment (mci) of ad, alzheimer's disease (ad) dementia